Artelo Biosciences (ARTL) Notes Payables (2017 - 2025)
Artelo Biosciences (ARTL) recorded Notes Payables of $437,000 in Q4 2025, down 50.1% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Notes Payables (2017 - 2025) Analysis & Trends
Starting with Q2 2017, Artelo Biosciences' Notes Payables history includes 4 quarters.
- The Q4 2025 figure is the lowest quarterly Notes Payables since Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Artelo Biosciences | 52,106.49 | -5.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 437,000.00 |
| Sep 30, 2025 | 875,000.00 |
| May 31, 2017 | 29,720.00 |
| Feb 28, 2017 | 29,569.00 |
API Access
Artelo Biosciences Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();